Intravenous iron reduced iron deficiency more effectively than oral iron, which is often distasteful, among pregnant women in Nigeria. However, no significant difference was found in the prevalence of ...

CHICAGO — In the IRONMAN trial, long-term IV iron supplementation in patients with HF and iron deficiency was safe and reduced risk for recurrent HF hospitalizations and CV death compared with usual ...

Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a ...

Ferumoxytol, a novel intravenous form of iron that permits rapid administration of large doses, has been shown to be effective for treating iron deficiency in chronic kidney disease (CKD) patients on ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...

This study investigated intravenous iron in hemodialysis patients with functional iron deficiency anemia. Maintaining a serum ferritin level of 600 to 700 ng/mL using approximately 200 mg/mo ...

Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis. High-dose intravenous (IV) iron reduces the risk for acute myocardial infarction in patients receiving ...

Patients who were hospitalized with acute heart failure and had iron deficiency were less likely to return to the hospital if given intravenous iron replacement, according to late-breaking research ...

Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research.

The hematologic investigation of patients with fatigue often ends when a normal hemoglobin level is reported. However, some patients with normal hemoglobin might have other evidence of iron deficiency ...